bioAffinity Technologies, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BIAFW | BDSX | BMRA | 8YY.SI | AIDX | ADPT | |
|---|---|---|---|---|---|---|
| Market cap | — | 226.74M | 7.98M | 41.60M | 2.92M | 4.26B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | -97.7 | 4.4 | — | — | -148.2 |
| Price/book | 0.0 | 24.8 | 2.2 | 24.0 | 1.7 | 18.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | — | +144.77% | −31.76% | +13.64% | −99.04% | +71.66% |
| Today | 0.00% | +2.09% | +2.06% | −4.00% | −2.55% | +3.53% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All BIAFW news ›bioAffinity Technologies, Inc. (NASDAQ:BIAF) Sees Significant Decline in Short Interest
Posted by Danessa Lincoln on Nov 2nd, 2026 Read Our Latest Report on BIAF bioAffinity Technologies, Inc is a biotechnology company focused on developing diagnostic and therapeutic products for cancer and other serious diseases. The…
bioAffinity Technologies Highlights Importance of Link Between Early Lung Cancer Detection and Curative Treatment During National Lung Cancer Awareness Month
Benefits of CyPath® Lung to be shared with North Carolina patient advocacy and healthcare community at November 5 “Battle of the Blues” Event The Company will join others committed to advancing lung cancer awareness, research, and patient…
bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026
Chief Medical Officer Gordon Downie, MD, to host CHEST 2026 Learning Theater on clinical use of CyPath® Lung Presentation to address current challenges in pulmonary nodule management a
bioAffinity Technologies expands Lung diagnostics pipeline into COPD and Asthma
bioAffinity Technologies CEO Maria Zennes joined Steve Darling from Proactive to discuss the company's noninvasive lung cancer detection technology, reported 200% year-over-year growth in the second quarter, insurance reimbursement and…
bioAffinity Technologies to Present CyPath Lung at CHEST 2026, Highlights Positive Research and Advisory Board Meeting
TradingView bioAffinity Technologies to Present CyPath Lung at CHEST 2026, Highlights Positive Research and Advisory Board Meeting bioAffinity Technologies will sponsor a CHEST 202
bioAffinity Technologies to Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026
Findings report on ability to measure cellular and soluble inflammatory protein biomarkers in sputum, including biologic drug targets Company advances research and development in diagnostic tests for major lung diseases building on CyPath®…
bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
BioSpace bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and
bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Stock Short Interest Climbs 334.6%
Posted by Mitch Edgeman on Oct 12th, 2026 bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) was the target of a significant increase in short interest during the month of September. As of September 30th, there was short…
bioAffinity Technologies Announces Notification of Japanese Patent Allowance Covering Noninvasive CyPath® Lung and AI-Built Algorithm
BioSpace bioAffinity Technologies Announces Notification of Japanese Patent Allowance Covering Noninvasive CyPath® Lung and AI-Built Algorithm Company’s expanding in
bioAffinity Technologies Raises ~$4 Million in Registered Direct, Adds PIPE Warrants
TradingView bioAffinity Technologies Raises ~$4 Million in Registered Direct, Adds PIPE Warrants bioAffinity Technologies completed a financing anchored by a Securities Purchase Agreement with an institutional inve
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com15
- stocktitan.net6
- biospace.com4
- businesswire.com2
- prnewswire.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 37 articles, not a forecast.